Insulin-like Growth Factor I Overexpression in Human Pancreatic Cancer: Evidence for Autocrine and Paracrine Roles

Cancer Research

Volumn 55, Issue 10, 1995, Pages 2007-2011

  Bergmann, Uwe ^a   Funatomi, Hitoshi ^a   Yokoyama, Munehiro ^a   Korc, Murray ^a   Beger, Hans G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BLOTTING, NORTHERN; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0028997487     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Silverberg, E., and Lubera, J. A. Cancer Statistics. Cancer J. Clin., 3: 3–39, 1989.
2. Gudjonsson, B. Cancer of the pancreas: 50 years of surgery. Cancer (Phila.), 60: 2284–2303, 1987.
3. Bos, J. L. Ras oncogenes in human cancer a review. Cancer Res., 49:4682–4689,1989.
4. Casey, G., Yamanaka, Y., Friess, H., Kobrin, M. S., Lopez, M. E., Buchler, M., Beger, H. G., and Korc, M. p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett., 69: 151–160, 1992.
5. Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Buchler, M., and Beger, H. G. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor α. J. Clin. Invest., 90: 1352–1360, 1992.
6. Friess, H., Yamanaka, Y., Buchler, M., Beger, H. G., Kobrin, M. S., Baldwin, R. L., and Korc, M. Enhanced expression of the type II transforming growth factor-β receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res., 53: 2704–2707, 1993.
7. Yamanaka, Y., Friess, H., Buchler, M., Beger, H. G., Uchida, E., Onda, M., Kobrin, M. S., and Korc, M. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res., 53: 5289–5296, 1993.
8. Daughaday, W. H., and Rotwein, P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrine Rev., 10: 68–91, 1989.
9. Frosch, R. G., Busby, W. H., and Schwander, J. Actions of insulin-like growth factors. Annu. Rev. Physiol., 47: 443–467, 1985.
10. Werner, H., Woloschak, M., Stannard, B., Shen-Or, Z., Roberts, C. T., Jr., and Le Roith, D. The insulin-like growth factor I receptor: molecular biology, heterogeneity, and regulation. In: D. Le Roith (ed.), Insulin-like Growth Factors: Molecular and Cellular Aspects, pp. 17–48. Boca Raton: CRC Press, 1991.
11. Macaulay, V. M. Insulin-like growth factors and cancer. Br. J. Cancer, 65: 311–320, 1992.
12. Daughaday, W. H. Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology, 127: 1–4, 1990.
13. Baserga, R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55: 249–252, 1995.
14. Pietrzkowski, Z., Lammers, R., Carpenter, G., Soderquist, A. M., Limardo, M., Phillips, P. D., Ullrich, A., and Baserga, R. Constitutive expression of IGF-1 and IGF-1 receptor abrogates all requirements for exogenous growth factors. Cell Growth & Differ., 3: 199–205, 1992.
15. Hermanek, P., and Sobin, L. H. TNM Classification of Malignant Tumours/UICC, International Union against Cancer, p. 65, New York: Springer Verlag, 1987.
16. Ullrich, A., Berman, C. H., Dull, T. H., Gray, A., and Lee, J. M. Isolation of the human insulin-like growth factor I gene using a single synthetic probe. EMBO J., 3: 361–364, 1984.
17. Ullrich, A., Gray, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., LeBon, T., Katchuria, S., Chen, E., Jacobs, S., Francke, D., Ramachandran, J., and Fujita-Yamaguchi, Y. Insulin-growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5: 2503–2512,1986.
18. Arrick, B., Korc, M., and Derynck, R. Differential regulation of expression of three transforming growth factor 0 species in human breast cancer cell lines by estradiol. Cancer Res., 50: 299–303, 1990.
19. Mossmann, P. B., and Young, L. L. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 49–53, 1983.
20. Baldwin, R. L., and Korc, M. Growth inhibition of human pancreatic carcinoma cells by transforming growth factor β-1. Growth Factors, 8: 23–34, 1993.
21. Raitano, A. B., Scuderi, P., and Korc, M. Binding and biological effects of tumor necrosis factor and γ interferon in human pancreatic carcinoma cells. Pancreas, 5: 267–277, 1990.
22. Han, V. K. M., Lund, P. K., Lee, D. C., and D'Ercole, A. J. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acid in the human fetus: identification, characterization, and tissue distribution. J. Clin. Endocrinol. Metab., 66: 422–429, 1988.
23. Kaleko, M., Rutter, W. J., and Miller, A. D. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol., 10: 464–473, 1990.
24. Prager, D., Li, H. L., Asa, S., and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl. Acad. Sci. USA, 91: 2181–2185, 1994.
25. Ambrose, D., Resnicoff, M., Coppola, D., Sell, C., Miura, M., Jameson, S., Baserga, R., and Rubin, R. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor. J. Cell. Physiol., 159: 92–100, 1994.
26. Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. Effect of null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol., 14: 3604–3612, 1994.
27. Kato, H., Faria, T. N., Stannard, B., Roberts, C. T., Jr., and LeRoitt, D. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. J. Biol. Chem., 268: 2655–2661, 1993.
28. Long, L., Nip, J., and Brodt, P. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res., 54: 3732–3737, 1994.